Related references
Note: Only part of the references are listed.Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
Jedd D. Wolchok et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
David R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Alan J. Korman et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Autophagy: A promising target for triple negative breast cancers
Yomna S. Abd El-Aziz et al.
PHARMACOLOGICAL RESEARCH (2022)
Tissue-specific tregs in cancer metastasis: opportunities for precision immunotherapy
Laura A. Huppert et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi et al.
CELL COMMUNICATION AND SIGNALING (2022)
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Sara G. Manore et al.
FRONTIERS IN ONCOLOGY (2022)
Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6
Andrew W. Chung et al.
NPJ BREAST CANCER (2022)
Neutrophils in cancer: heterogeneous and multifaceted
Catherine C. Hedrick et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Urogenital Schistosomiasis-History, Pathogenesis, and Bladder Cancer
Lucio Lara Santos et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages
Zhanke He et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer
Jean Bourhis et al.
CANCER TREATMENT REVIEWS (2021)
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale et al.
NATURE MEDICINE (2021)
First-line atezolizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: a cost-effectiveness analysis from China
Zhiguang Yang et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2021)
Exosomes Derived From Macrophages Enhance Aerobic Glycolysis and Chemoresistance in Lung Cancer by Stabilizing c-Myc via the Inhibition of NEDD4L
Huan Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities
Sapana Bansod et al.
CANCERS (2021)
Novel therapies emerging in oncology to target the TGF-β pathway
Byung-Gyu Kim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners
Marek Z. Wojtukiewicz et al.
CANCER AND METASTASIS REVIEWS (2021)
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid for Tumors
Leigh Marcus et al.
CLINICAL CANCER RESEARCH (2021)
Inflammation-Induced Tumorigenesis and Metastasis
Sana Hibino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf et al.
FRONTIERS IN IMMUNOLOGY (2021)
Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
Yanan Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Kai Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan-Tong Liu et al.
THERANOSTICS (2021)
Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Chunxiao Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
INTERNATIONAL IMMUNOLOGY (2021)
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
Xuefei Zhou et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
Dongbo Li et al.
CANCER SCIENCE (2020)
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Andrew M. K. Law et al.
CELLS (2020)
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
Clement Anfray et al.
CELLS (2020)
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Devalingam Mahalingam et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer
Yuxin Shu et al.
IMMUNOLOGY (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
Reem Saleh et al.
CANCER LETTERS (2020)
The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis
Jingjie Chen et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Targeting tumor-associated macrophages for cancer immunotherapy
Yongheng Shu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
MIF-Dependent Control of Tumor Immunity
Jordan T. Noe et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases
Paulraj Kanmani et al.
BIOMEDICINES (2020)
Immune modulatory effects of oncogenic KRAS in cancer
Shaima'a Hamarsheh et al.
NATURE COMMUNICATIONS (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Immune crosstalk in cancer progression and metastatic spread: a complex conversation
Hannah Garner et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
Xiaolan Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Evolving complexity of MIF signaling
Stanislovas S. Jankauskas et al.
CELLULAR SIGNALLING (2019)
Mesenchymal stem cells: From regeneration to cancer
Peishan Li et al.
PHARMACOLOGY & THERAPEUTICS (2019)
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation
Xuegiang Gao et al.
BREAST CANCER (2019)
Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways
Ming Jiang et al.
THORACIC CANCER (2019)
Interleukin 6 signaling maintains the stem-like properties of bladder cancer stem cells
Hua Wei
TRANSLATIONAL CANCER RESEARCH (2019)
Macrophages and Metabolism in the Tumor Microenvironment
Ilio Vitale et al.
CELL METABOLISM (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment
Jing Wang et al.
CANCER MEDICINE (2019)
Myeloid-Derived Lymphatic Endothelial Cell Progenitors Significantly Contribute to Lymphatic Metastasis in Clinical Breast Cancer
Lisa Volk-Draper et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Mariya Lazarova et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
Laura Lorenzo-Sanz et al.
CANCER MICROENVIRONMENT (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis
Marko Roblek et al.
MOLECULAR CANCER RESEARCH (2019)
Cancer stem cells as targets for immunotherapy
Amy S. Codd et al.
IMMUNOLOGY (2018)
Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
Elham Safarzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma
Y. Qiao et al.
ONCOGENE (2018)
Integration of radiation and immunotherapy in breast cancer - Treatment implications
Jason C. Ye et al.
BREAST (2018)
Tumor-Stroma IL1 beta-IRAK4 Feedforward Circuitry DrivesTumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
Daoxiang Zhang et al.
CANCER RESEARCH (2018)
Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis
Milka Koupenova et al.
CIRCULATION RESEARCH (2018)
Macrophages: Their role, activation and polarization in pulmonary diseases
Shweta Arora et al.
IMMUNOBIOLOGY (2018)
Role of Human Macrophage Polarization in Inflammation during Infectious Diseases
Chiraz Atri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
TGF beta pathway inhibition in the treatment of non-small cell lung cancer
Pinar O. Eser et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
Si-Qi Qiu et al.
CANCER TREATMENT REVIEWS (2018)
Cemiplimab: First Global Approval
Anthony Markham et al.
DRUGS (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure
Steven K. Libutti et al.
Oncotarget (2018)
IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
Landon Browning et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Immunotherapy and Prevention of Pancreatic Cancer
Alexander H. Morrison et al.
TRENDS IN CANCER (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
Le-Xing Yu et al.
NPJ PRECISION ONCOLOGY (2018)
Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
Chiara Lazzari et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
Yaqing Zhang et al.
GUT (2017)
From inflammation to cancer
A. Korniluk et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2017)
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape
Malte Mohme et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor-associated macrophages: implications in cancer immunotherapy
Amy J. Petty et al.
IMMUNOTHERAPY (2017)
Myeloid-derived suppressor cellsa new therapeutic target to overcome resistance to cancer immunotherapy
Jason A. Chesney et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Purnima Bhat et al.
CELL DEATH & DISEASE (2017)
Inflammatory responses and inflammation-associated diseases in organs
Linlin Chen et al.
Oncotarget (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
Trung Vu et al.
CANCERS (2017)
Natural killer cells and tumor metastasis
Hwan Hee Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors
Shannon M. Steinberg et al.
CANCER RESEARCH (2017)
Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling
Huan Yan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Characteristics and Significance of the Pre-metastatic Niche
Yang Liu et al.
CANCER CELL (2016)
Targeting regulatory T cells in tumors
Chang Liu et al.
FEBS JOURNAL (2016)
Roles of regulatory T cells in cancer immunity
Yoshiko Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2016)
Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
Bo Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
Yasushi Shintani et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities
Ciaran O'Reilly et al.
MEDICINAL RESEARCH REVIEWS (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Role of interleukin-6 in cancer progression and therapeutic resistance
Neeraj Kumari et al.
TUMOR BIOLOGY (2016)
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
Tae-Hwe Heo et al.
ONCOTARGET (2016)
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
Leilei Tao et al.
SCIENTIFIC REPORTS (2016)
Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding
Marko Roblek et al.
NEOPLASIA (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Interleukin-6 as a Therapeutic Target
Jean-Francois Rossi et al.
CLINICAL CANCER RESEARCH (2015)
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Nonalcoholic fatty liver disease and hepatic cirrhosis: comparison with viral hepatitis-associated steatosis
Yuki Haga et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
Stephan Herbertz et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells
Wei Cao et al.
SCIENTIFIC REPORTS (2015)
Cancer metastases: challenges and opportunities
Xiangming Guan
ACTA PHARMACEUTICA SINICA B (2015)
The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer
David P. Rose et al.
CANCERS (2015)
IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation
Chen-Chi Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
Kamolporn Amornsupak et al.
BMC CANCER (2014)
Inflammation Amplifier, a New Paradigm in Cancer Biology
Toru Atsumi et al.
CANCER RESEARCH (2014)
Stromal-dependent tumor promotion by MIF family members
Robert A. Mitchell et al.
CELLULAR SIGNALLING (2014)
Interplay between DNA repair and inflammation, and the link to cancer
Dawit Kidane et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment
Vinit Kumar et al.
IMMUNOLOGY (2014)
A Macrophage-Dominant PI3K Isoform Controls Hypoxia-Induced HIF1α and HIF2α Stability and Tumor Growth, Angiogenesis, and Metastasis
Shweta Joshi et al.
MOLECULAR CANCER RESEARCH (2014)
Involvement of Urokinase-Type Plasminogen Activator System in Cancer: An Overview
Ahmed H. Mekkawy et al.
MEDICINAL RESEARCH REVIEWS (2014)
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
A. Casazza et al.
ONCOGENE (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
MIF Family Members Cooperatively Inhibit p53 Expression and Activity
Stephanie E. Brock et al.
PLOS ONE (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
The metastasis-promoting roles of tumor-associated immune cells
Heath A. Smith et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Pancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors
Barbara Vizio et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Tumor angiogenesis and lymphangiogenesis: Tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms
Fausto Gueths Gomes et al.
LIFE SCIENCES (2013)
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Sakari Vanharanta et al.
NATURE MEDICINE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor
Yuxin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer
Gonzalo Carrasco et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav et al.
NATURE REVIEWS CANCER (2013)
Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis
Takahiro Shimizu et al.
CANCER SCIENCE (2012)
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Masahiko Mihara et al.
CLINICAL SCIENCE (2012)
Molecular Link Mechanisms between Inflammation and Cancer
D. B. Vendramini-Costa et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Impact of the carotenoid astaxanthin on phagocytic capacity and ROS/RNS production of human neutrophils treated with free fatty acids and high glucose
Beatriz Alves Guerra et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils
Stephen J. Galli et al.
NATURE IMMUNOLOGY (2011)
The Role of Platelets in Atherothrombosis
Zane S. Kaplan et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Dysregulated pH: a perfect storm for cancer progression
Bradley A. Webb et al.
NATURE REVIEWS CANCER (2011)
Tumour escape mechanisms and their therapeutic implications in combination tumour therapy
Sujit K. Bhutia et al.
CELL BIOLOGY INTERNATIONAL (2010)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Mast cells and pancreatic cancer
Theoharis C. Theoharides
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cytokine-based transformation of immune surveillance into tumor-promoting inflammation
J. B. Mumm et al.
ONCOGENE (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
H. Lue et al.
ONCOGENE (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Ksenya Shchors et al.
GENES & DEVELOPMENT (2006)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells
MK Levings et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth
J Nishihira
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
Share Paper
